Opexa Therapeutics To Present At BIO Investor Forum

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders including multiple sclerosis (MS) and neuromyelitis optica (NMO), today announced that Neil K. Warma, President and Chief Executive Officer, will present at the 14th Annual BIO Investor Forum on Wednesday, October 21, 2015, at 10:00 a.m. PT. The conference will be held at the Parc 55 Hotel in San Francisco, California.

Help employers find you! Check out all the jobs and post your resume.